CALIFORNIA -- California health officials are recommending a temporary halt to distribution of a particular lot of Moderna's COVID-19 vaccine out of concern over allergic reactions. More than 330,000 ...
Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a ...
"The public understandably has been concerned about reports of rare, severe allergic reactions to the Moderna and Pfizer-BioNTech COVID-19 vaccines," Dr. Anthony Fauci, director of the National ...
April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking oral presentations on revaccination data for both mRNA-1010, its investigational seasonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results